시장보고서
상품코드
1619216

세계의 혈액검사 시장 - 규모, 점유율, 성장 분석 : 유형별, 방법별, 최종사용자별, 지역별 산업 예측(2024-2031년)

Blood Testing Market Size, Share, Growth Analysis, By Type (Glucose Testing, Lipid Panel Testing), By Methods (Manual Blood Testing, Automated Blood Testing), By End User, By Region - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈액검사의 세계 시장 규모는 2022년 956억 5,000만 달러로 평가되었고, 2023년 1,034억 9,000만 달러에서 2031년에는 1,944억 2,000만 달러로 성장해 예측기간 중(2024-2031년)의 CAGR은 8.2%로 성장할 전망입니다.

세계의 혈액 검사 시장은 정부 부문과 민간 부문 모두의 의료 지출 증가로 큰 성장을 이룰 것으로 예측되고 있습니다. 만성질환에 대한 의식을 높이고 있어 혈액검사 수요를 한층 더 촉진하고 있습니다. 질병 증가는 건강 평가 제품에 대한 큰 수요를 창출합니다. 당국의 지원 급증과 건강에 대한 관심 증가는 혈액검사 분야의 사업 전체에 유리한 기회를 제공해 향후 수년간 시장의 견조한 확대를 자리매김하고 있습니다.

목차

소개

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터의 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 억제요인과 과제
  • Porter's Five Forces 분석

주요 시장 인사이트

  • 중요성공요인
  • 경쟁도
  • 주요 투자 기회
  • 시장 생태계
  • 시장의 매력 지수(2023년)
  • PESTEL 분석
  • 거시경제지표
  • 밸류체인 분석
  • 가격 분석
  • 기술의 진보
  • 규제 상황
  • 사례 연구
  • 특허 분석

혈액검사 시장 규모 : 유형별 & CAGR(2024-2031)

  • 시장 개요
  • 포도당 검사
  • 지질 패널 검사
  • 전립선 특이 항원(PSA) 검사
  • 혈중 우레아 질소(BUN) 검사
  • 갑상선 자극 호르몬 검사
  • 기타 유형
    • 직접 LDL 검사
    • 테스토스테론 검사

혈액검사 시장 규모 : 방법별 & CAGR(2024-2031)

  • 시장 개요
  • 수동 혈액 검사
  • 자동 혈액 검사

혈액 검사 시장 규모 : 최종 사용자별 & CAGR(2024-2031)

  • 시장 개요
  • 진단 실험실
  • 병원
  • 기타 최종 사용자

혈액검사 시장 규모 : 지역별 & CAGR(2024-2031)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5개사 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채용한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2023년)
  • 주요 기업의 기업 프로파일
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 수익의 전년 대비 비교(2021-2023)

주요 기업 프로파일

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • bioMerieux
  • Quest Diagnostics Incorporated
  • Biomerica
  • BD
  • Siemens Healthineers AG
  • Danaher Corporation
  • Trinity Biotech Plc
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Dr Lal PathLabs Limited
  • Alere Inc.
  • Cepheid Corporation

결론과 권장사항

JHS 25.01.06

Global Blood Testing Market size was valued at USD 95.65 billion in 2022 and is poised to grow from USD 103.49 billion in 2023 to USD 194.42 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The global blood testing market is projected to experience significant growth, fueled by increasing medical expenditures from both government and private sectors. Multinational healthcare organizations are actively developing innovative techniques and raising awareness about chronic diseases, further driving demand for blood testing. The rise in chronic disease prevalence, especially diabetes-expected to affect 783 million adults by 2031-will create substantial demand for health assessment products. Regulatory bodies like CMS and FDA are pivotal in promoting CLIA-compliant diagnostic tests that enhance early disease detection. This surge in regulatory support and rising health concerns offers lucrative opportunities for operational entities within the blood testing sector, positioning it for robust market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Testing Market Segmental Analysis

Global Blood Testing Market is segmented by type, methods, end user and region. Based on type, the market is segmented into glucose testing, lipid panel testing, prostate specific antigen (PSA) testing, blood urea nitrogen (BUN) testing, thyroid stimulating hormone testing and other types (Direct LDL Testing, Testosterone Testing). Based on methods, the market is segmented into manual blood testing and automated blood testing. Based on end user, the market is segmented into diagnostic laboratories, hospitals and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Testing Market

The Global Blood Testing market is significantly influenced by several key drivers that contribute to its growth. One of the most crucial factors is the influx of external funding directed towards clinical studies focused on innovating advanced diagnostic technologies. Additionally, as patient awareness regarding various self-testing and home diagnostic options rises, this trend is expected to further boost the market. Moreover, the increasing prevalence of chronic diseases, coupled with a heightened demand for rapid health assessment products, suggests a strong upward trajectory for the global blood testing market in the upcoming years. These elements collectively create a favorable environment for market expansion.

Restraints in the Global Blood Testing Market

The Global Blood Testing market faces significant challenges that may impede its growth, particularly in developing nations like India, Indonesia, and Malaysia. A key restraint is the limited awareness among patients regarding advanced technological devices, which can inhibit adoption rates. Additionally, the high costs associated with these devices and self-testing kits are anticipated to further suppress market demand in the foreseeable future. These factors collectively contribute to a slower market advancement, highlighting the need for increased education and more affordable options to enhance accessibility and utilization of blood testing technologies in these regions.

Market Trends of the Global Blood Testing Market

The global blood testing market is witnessing significant growth driven by advancements in technology and a surge in demand for accurate diagnostic solutions. Key players are increasingly leveraging innovations, particularly Artificial Intelligence, to enhance the precision and speed of disease detection, enabling early intervention and improved patient outcomes. This focus on integrating cutting-edge technologies not only streamlines testing processes but also caters to the evolving needs of healthcare providers and patients alike. As a result, the market is poised for expansion, with a notable emphasis on developing user-friendly products that enhance accessibility and efficiency, thereby reshaping the landscape of blood diagnostics worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies
  • Patent Analysis

Global Blood Testing Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • Glucose Testing
  • Lipid Panel Testing
  • Prostate Specific Antigen (PSA) Testing
  • Blood Urea Nitrogen (BUN) Testing
  • Thyroid Stimulating Hormone Testing
  • Other Types
    • Direct LDL Testing
    • Testosterone Testing

Global Blood Testing Market Size by Methods & CAGR (2024-2031)

  • Market Overview
  • Manual Blood Testing
  • Automated Blood Testing

Global Blood Testing Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Diagnostic Laboratories
  • Hospitals
  • Other End Users

Global Blood Testing Market Size & CAGR (2024-2031)

  • North America (Type, Methods, End User)
    • USA
    • Canada
  • Europe (Type, Methods, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Methods, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Methods, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Methods, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerica
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trinity Biotech Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr Lal PathLabs Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alere Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제